To further determine if IFN-γ action on endothelial cells alone is sufficient to suppress tumor growth, we performed ACT against IFN-γR1KO-MCA-205-OVA-GFP tumors in the bone marrow chimeras. The gene discussed is IFNG; the disease is neoplasm.